Improved survival in stage IB/II melanoma using Canvaxin™, a polyvalent cancer vaccine

被引：0
|
作者：
Faries, MB [1 ]
Foshag, LJ [1 ]
Essner, R [1 ]
Wanek, LA [1 ]
Morton, DL [1 ]
机构：
[1] John Wayne Canc Inst, Santa Monica, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2005年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [31] Poorer Survival in Stage IB Lung Cancer Patients After Pneumonectomy
    Rodriguez, Maria
    Gomez Hernandez, Maria Teresa
    Novoa, Nuria M.
    Luis Aranda, Jose
    Jimenez, Marcelo F.
    Varela, Gonzalo
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (05): : 223 - 226
  • [32] Prognostic significance of monocytes derived IL-10 expression in advances stage(IV) melanoma patients receiving a polyvalent therapeutic cancer vaccine
    Torisu-Itakura, H
    Lee, J
    Huynh, Y
    Morton, D
    Essner, R
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S44 - S44
  • [33] Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma:: basis for polyvalent CT vaccine strategies
    Sahin, U
    Türeci, Ö
    Chen, YT
    Seitz, G
    Villena-Heinsen, C
    Old, LJ
    Pfreundschuh, M
    INTERNATIONAL JOURNAL OF CANCER, 1998, 78 (03) : 387 - 389
  • [34] PROLONGATION OF SURVIVAL IN METASTATIC MELANOMA AFTER ACTIVE SPECIFIC IMMUNOTHERAPY WITH A NEW POLYVALENT MELANOMA VACCINE (VOL 216, PG 463, 1992)
    MORTON, DL
    FOSHAG, LJ
    HOON, DSB
    ANNALS OF SURGERY, 1993, 217 (03) : 309 - 309
  • [35] Conditional survival (CS) in patients with stage II melanoma.
    Gamerman, Victoria
    Karakousis, Giorgos Constantine
    Guerry, DuPont
    Gimotty, Phyllis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] IMPROVED SURVIVAL OF MELANOMA PATIENTS WITH DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO MELANOMA VACCINE IMMUNIZATION
    BYSTRYN, JC
    ORATZ, R
    ROSES, DF
    HARRIS, MN
    HENN, M
    LEW, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (04) : 549 - 549
  • [37] IMPROVED SURVIVAL OF MELANOMA PATIENTS WITH DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO MELANOMA VACCINE IMMUNIZATION
    BYSTRYN, JC
    ORATZ, R
    ROSES, DF
    HARRIS, MN
    HENN, M
    LEW, R
    CLINICAL RESEARCH, 1991, 39 (02): : A503 - A503
  • [38] The effect of preferentially expressed antigen in melanoma (PRAME) expression status on survival in stage II and stage III colon cancer
    Ogul, Ali
    Paydas, Semra
    Doran, Figen
    Erdogan, Kivilcim Eren
    Tohumcuoglu, Mert
    Buyuksimsek, Mahmut
    Mirili, Cem
    Yetisir, Abdullah Evren
    JOURNAL OF BUON, 2021, 26 (03): : 992 - 1001
  • [39] Adherence to NCCN Guidelines is Associated with Improved Survival in High Risk Stage II and Stage III Colon Cancer
    Boland, G. M.
    Chiang, Y.
    Chagpar, R.
    Xing, Y.
    Hu, C.
    Feig, B. W.
    Chang, G. J.
    You, Y.
    Cormier, J. N.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S100 - S100
  • [40] Improved Survival for Stage IV Melanoma From an Unknown Primary Site
    Lee, Chris C.
    Faries, Mark B.
    Wanek, Leslie A.
    Morton, Donald L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3489 - 3495
12345